1 year return (CAGR)
-13.64%
Regenxbio Inc Exchange (NASDAQ, USD)
RGNX
7.95
-0.74 (-8.57%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-22.74%
5 year return (CAGR)
-25.38%
10 year return (CAGR)
-3.91%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
524.47M
Price/Sales
3.01
Ent value
802.84M
Price/Book
7.31
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
4.73%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 8.69 |
| Daily high | 8.75 |
| Daily low | 7.78 |
| Daily Volume | 1.29M |
| All-time high | 82.15 |
| 1y analyst estimate | 23.73 |
| Beta | 0.93 |
| EPS (TTM) | -3.71 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| RGNX | S&P500 | |
| Current price drop from All-time high | -90.33% | -2.63% |
| Highest price drop | -93.54% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -58.53% | -10.68% |
| Avg time to new high | 75 days | 12 days |
| Max time to new high | 2057 days | 1805 days |
News
